COSCIENS Biopharma Inc. Reports Q2 2026 Results
TORONTO, ONTARIO, Aug. 11, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCI.F) (“COSCIENS” or the “Company”) today reported its financial and operating results for the second…
- COSCIENS Biopharma reported Q2 2026 results
- Company underwent share reorganization and suspended reporting
- Forward-looking statements comply with securities legislation
